24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
PolyPid
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:56
Being polite to ChatGPT? It turns out it costs OpenAI millions
16:30
A $35 million VC fund was born at a Gaza war crossing
14:48
Cyvore emerges from stealth to secure digital workspaces
14:42
Romance, lies, and ChatGPT: The scandal shaking Tel Aviv’s startup scene
More stories
Buzz
Most popular
Daily
Weekly
1
“I don’t want to be the richest man in the cemetery” — Morris Kahn on giving it all away at 95
2
Romance, lies, and ChatGPT: The scandal shaking Tel Aviv’s startup scene
3
Cyvore emerges from stealth to secure digital workspaces
4
A $35 million VC fund was born at a Gaza war crossing
5
From startup exits to psychedelic therapy: Eyal Gura’s new mission
More news
PolyPid
2 stories about PolyPid
“In the biotech industry, the one thing that is missing more than anything else is funding"
17.10.21
|
CTech
Dikla Czackes Akselbrad, executive vice president and CFO of PolyPid, joins Michael Matias to discuss her bio-pharmaceutical company
Drug Conduction Company Prepares for Nasdaq IPO
08.10.17
|
Golan Hazani
Clinical stage PolyPid develops technology for the predetermined, controlled and localized release of drugs at a targeted site
